Mark Walterfang Selected Research

Alcoholism (Alcohol Abuse)

12/2012

Peduncular hallucinosis secondary to central pontine myelinolysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Walterfang Research Topics

Disease

13	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2022 - 01/2006
7	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2022 - 01/2006
6	Dementia (Dementias) 11/2022 - 12/2006
6	Frontotemporal Dementia (Semantic Dementia) 10/2022 - 05/2012
5	Atrophy 12/2018 - 12/2006
4	Schizophrenia (Dementia Praecox) 10/2022 - 12/2006
4	Psychotic Disorders (Schizoaffective Disorder) 04/2012 - 01/2006
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2014
3	Cognitive Dysfunction 01/2022 - 12/2018
3	Deglutition Disorders (Dysphagia) 01/2021 - 10/2012
3	Phenylketonurias (Phenylketonuria) 01/2021 - 07/2013
3	Disease Progression 01/2020 - 07/2012
2	Traumatic Brain Injuries (Traumatic Brain Injury) 08/2022 - 07/2020
2	Wounds and Injuries (Trauma) 04/2022 - 06/2020
2	Feeding and Eating Disorders (Eating Disorder) 04/2022 - 06/2020
2	Mental Disorders (Mental Disorder) 01/2022 - 01/2020
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2020 - 08/2009
2	Aspiration Pneumonia 01/2018 - 10/2012
2	Neurologic Manifestations (Neurological Manifestations) 01/2018 - 10/2012
2	Cerebrotendinous Xanthomatosis 04/2014 - 07/2013
2	Inborn Urea Cycle Disorders 04/2014 - 07/2013
2	Acute Intermittent Porphyria (Porphyria, Acute) 04/2014 - 07/2013
2	Hepatolenticular Degeneration (Wilson's Disease) 04/2014 - 01/2013
2	Neuroacanthocytosis 04/2014 - 04/2011
2	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 07/2013 - 01/2013
2	Epilepsy (Aura) 12/2010 - 12/2007
2	Brain Diseases (Brain Disorder) 07/2008 - 01/2007
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 11/2022
1	Treatment-Resistant Schizophrenia 10/2022
1	Confusion (Bewilderment) 08/2022
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2022
1	Lewy Body Disease (Lewy Body Dementia) 01/2022
1	Neurobehavioral Manifestations 01/2021
1	succinic semialdehyde dehydrogenase deficiency 01/2020
1	Neuroinflammatory Diseases 01/2020
1	Major Depressive Disorder (Major Depressive Disorders) 01/2020
1	Mood Disorders (Mood Disorder) 01/2020
1	Perceptual Disorders (Hemispatial Neglect) 02/2018
1	Hyperammonemia 01/2018
1	Homocystinuria 04/2014
1	Homocysteinemia 04/2014
1	Ataxia (Dyssynergia) 04/2014
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2014
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 07/2013
1	Maple Syrup Urine Disease 07/2013
1	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 07/2013
1	alpha-Mannosidosis 07/2013
1	GM2 Gangliosidoses (GM2 Gangliosidosis) 07/2013
1	Huntington Disease (Huntington's Disease) 01/2013
1	Weight Loss (Weight Reduction) 01/2013
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2013
1	Binge-Eating Disorder (Binge Eating Disorder) 01/2013
1	Anorexia 01/2013
1	Bulimia Nervosa 01/2013
1	Alcoholism (Alcohol Abuse) 12/2012
1	Central Pontine Myelinolysis 12/2012

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 11/2022 - 05/2012
7	miglustat (Zavesca)FDA Link 01/2021 - 10/2012
7	LipidsIBA 01/2018 - 07/2008
4	CholesterolIBA 01/2022 - 01/2006
3	IronIBA 01/2018 - 12/2006
2	Olanzapine (Zyprexa)FDA Link 08/2022 - 07/2020
2	Selenic AcidIBA 01/2022 - 11/2020
2	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 01/2021 - 01/2019
2	HomocysteineIBA 04/2014 - 07/2013
2	Neurotransmitter Agents (Neurotransmitter)IBA 07/2013 - 12/2007
2	Biological ProductsIBA 12/2007 - 09/2006
1	Clozapine (Clozaril)FDA LinkGeneric 10/2022
1	Proteins (Proteins, Gene)FDA Link 10/2022
1	N 30IBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	C-Reactive ProteinIBA 01/2020
1	LigandsIBA 01/2020
1	MelatoninIBA 01/2020
1	Succinate-Semialdehyde Dehydrogenase (Succinic Semialdehyde Dehydrogenase)IBA 01/2020
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2019
1	Hallucinogens (Psychedelics)IBA 02/2018
1	CopperIBA 01/2018
1	Oxidoreductases (Dehydrogenase)IBA 04/2014
1	Phosphotransferases (Kinase)IBA 04/2014
1	Niemann-Pick C1 ProteinIBA 03/2014
1	MetalsIBA 03/2014
1	MonosaccharidesIBA 01/2013
1	Topiramate (Topamax)FDA LinkGeneric 01/2013
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2013
1	sulfamic acid (ammonium sulfamate)IBA 01/2013
1	SodiumIBA 12/2012
1	GlycosphingolipidsIBA 07/2012
1	LithiumIBA 04/2012
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2011
1	Valproic Acid (Depakote)FDA LinkGeneric 12/2010
1	Temazepam (Nocturne)FDA LinkGeneric 03/2010
1	Antipsychotic Agents (Antipsychotics)IBA 03/2010
1	Carrier Proteins (Binding Protein)IBA 08/2009
1	UbiquitinIBA 08/2009

Therapy/Procedure

5	Therapeutics 01/2020 - 07/2011
1	Home Nursing (Nursing, Home) 06/2022
1	Activities of Daily Living (ADL) 01/2020